Richard Conway RichardPAConway
5 years 11 months ago
Dr Quinn presenting on tocilizumab effects on PET in GCA. Abstr#514 @rheumnow #ACR20 My concern is this, persistent low grade activity on toc that returns on stopping https://t.co/nB0C1AEjbN
Janet Pope Janetbirdope
5 years 11 months ago
Save your $ as starting ERA with MTX works vs initial bDMARD. 470 w ERA given Rx based on DAS. Strategies MTX, BDMARD, one to other or vice versa. Not RCT- if not needed to stepup you did well as did stepdown. Not a #gamechanger @RheumNow @CRASCRRheum abstr#221 #ACR20 https://t.co/o1L3LlpIlm
Robert B Chao, MD doctorRBC
5 years 11 months ago
Ultrasound in PsA:
PsA pts with fibromyalgia were associated with higher non-MDA, CPDAI, PASDAS scores but NOT higher US scores of the joints, tendons, and entheses.
@RheumNow #ACR20 #ACRbest Abs#0315 https://t.co/dapIk1rWQm
Dr. Antoni Chan synovialjoints
5 years 11 months ago
If the synovio-entheseal complex is important in the pathogenesis of psoriatic arthritis, how do you assess the entheses in clinic? @RheumNow #ACR20
Despite increased awareness and better diagnostic modalities at hand, early diagnosis of psoriatic arthritis (PsA) still remains a huge unmet need. Broad spectrum of PsA manifestations, often gradual and subtle symptom development, along with lack of specific serological testing contributes to the challenge.
Dr. Antoni Chan synovialjoints
5 years 11 months ago
Another interesting study demonstrating the use of ultrasound to assess psoriatic arthritis. In very early, DMARD naïve PsA, clinically swollen joints are associated with PD synovitis, but tender, non-swollen joints are not @RheumNow #ACR20 Abst#313
Mrinalini Dey DrMiniDey
5 years 11 months ago
Following promising data presented at today's poster session, results from RELIEF #Behcets study show #apremilast leads to ↓ rates of new/recurrent/worsening oral ulcers, skin lesions & #arthritis compared to placebo at 12wks.
Abs#0512 #ACR20 @RheumNow
https://t.co/O1dstY5WlL https://t.co/0djnUGw0Hg
k dao KDAO2011
5 years 11 months ago
Another study on rheum pt outcomes w/#COVID19: similar outcomes as nonrheum pts. MGH/JHU/Brigham 143 rheum vs 688 nonrheum. No⬆️risk in rheums after adjusting for race/smoking/comorbidities for: hospitalizations, mech ventil'n 3. ICU 4. death #ACR20 Abstr#L01 @RheumNow https://t.co/362UZUe5dg
Richard Conway RichardPAConway
5 years 11 months ago
Prof Hatemi report on apremilast in Behcets disease. We know it improves oral ulcers. Now shown to improve skin lesions and arthritis. @rheumnow #ACR20 Abstr#512 https://t.co/BwIqio6dzq
Robert B Chao, MD doctorRBC
5 years 11 months ago
DISCOVER-2 (52 wk study) Guselkumab 100mg q4wk and q8wk for tx of PsA 1️⃣Sustained responses in: ACR20/50/70, PASI90/100, HAQ-DI, MDA/VLDA, QoL 2️⃣Improvement enthesitis/dactylitis 3️⃣No increase rate of serious infection @RheumNow #ACR20 Abs#0506 https://t.co/7MXYTucVZ9
Dr. Antoni Chan synovialjoints
5 years 11 months ago
The presence of fibromyalgia in psoriatic arthritis correlates with the clinical outcome scores. Ultrasound evaluation can be useful to evaluate disease activity in the presence of fibromyalgia @rheumnow #ACR20 Abstr#315 #ACRbest
Dr. Rachel Tate uptoTate
5 years 11 months ago
“Rheumatology comes in as the #2 specialty utilizing teleheath in a survey by Doximity.” Dr. C. Peoples discussing teleheath and COVID-19. “The elephant in the room is the physical exam!” #ACR20 @RheumNow
Results of the MAXIMISE trial show that Secukinumab provided clinical improvement and reduction in inflammatory MRI lesions in patients with psoriatic arthritis and axial disease through week 52.
Eric Dein ejdein1
5 years 11 months ago
How do you treat ACPA+, subclinical synovitis (US/MRI+)? Abst#0481 reviews 3 cohorts for progression to clinical inflam arthritis. 44-68% did not progress to IA in 1 year, is DMARD over treating? #ACR20 #ACRBest @RheumNow
Dr. Rachel Tate uptoTate
5 years 11 months ago
Dr. Phillips touches on a few things to consider how teleheath has changed the delivery of care due to COVID-19. Planning your post-pandemic business strategy, due demand for our specialty, is important. #ACR20 @RheumNow https://t.co/A2dsVy1KSg
